2021. Cost-Effectiveness of First- and Second-Step Treatment Strategies for Major Depressive Disorder : A Rapid Review.
作者: Andreea Dobrescu.;Andrea Chapman.;Lisa Affengruber.;Emma Persad.;Ana Toromanova.;Gernot Wagner.;Irma Klerings.;Robert Emprechtinger.;Gerald Gartlehner.
来源: Ann Intern Med. 2023年176卷2期212-216页
Major depressive disorder (MDD) is the most prevalent, disabling form of depression, with a high economic effect.
2034. Hydroxychloroquine Dose and Risk for Incident Retinopathy : A Cohort Study.
作者: Ronald B Melles.;April M Jorge.;Michael F Marmor.;Baijun Zhou.;Carol Conell.;Jingbo Niu.;Natalie McCormick.;Yuqing Zhang.;Hyon K Choi.
来源: Ann Intern Med. 2023年176卷2期166-173页
Hydroxychloroquine is recommended for all patients with systemic lupus erythematosus and is often used for other inflammatory conditions, but a critical long-term adverse effect is vision-threatening retinopathy.
2035. Epstein-Barr Viral Load Monitoring Strategy and the Risk for Posttransplant Lymphoproliferative Disease in Adult Liver Transplantation : A Cohort Study.
作者: Bastian N Ruijter.;Ron Wolterbeek.;Mitchell Hew.;Marjolein van Reeven.;Danny van der Helm.;Jeroen Dubbeld.;Maarten E Tushuizen.;Herold Metselaar.;Ann C T M Vossen.;Bart van Hoek.
来源: Ann Intern Med. 2023年176卷2期174-181页
Primary infection with or reactivation of Epstein-Barr virus (EBV) can occur after liver transplant (LT) and can lead to posttransplant lymphoproliferative disease (PTLD). In pediatric LT, an EBV-DNA viral load (EBV VL) monitoring strategy, including the reduction of immunosuppression, has led to a lower incidence of PTLD. For adult LT recipients with less primary infection and more EBV reactivation, it is unknown whether this strategy is effective.
2039. Migraine.
Migraine affects about 1 billion people worldwide, and up to 15% of adults in the United States have migraine attacks in any given year. Migraine is associated with substantial adverse socioeconomic and personal effects. It is the second leading cause of years lived with disability worldwide for all ages and the leading cause in women aged 15 to 49 years. Diagnostic uncertainty increases the likelihood of unnecessary investigations and suboptimal management. This article advises clinicians about diagnosing migraine, ruling out secondary headache disorders, developing acute and preventive treatment plans, and deciding when to refer the patient to a specialist.
2040. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
作者: Sankar D Navaneethan.;Sophia Zoungas.;M Luiza Caramori.;Juliana C N Chan.;Hiddo J L Heerspink.;Clint Hurst.;Adrian Liew.;Erin D Michos.;Wasiu A Olowu.;Tami Sadusky.;Nikhil Tandon.;Katherine R Tuttle.;Christoph Wanner.;Katy G Wilkens.;Jonathan C Craig.;David J Tunnicliffe.;Marcello Tonelli.;Michael Cheung.;Amy Earley.;Peter Rossing.;Ian H de Boer.;Kamlesh Khunti.
来源: Ann Intern Med. 2023年176卷3期381-387页
The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease is an update of the 2020 guideline from Kidney Disease: Improving Global Outcomes (KDIGO).
|